SVRA CIK: 1160308

Savara Inc

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−40.1
FY22:
−34.6
FY23:
−51.1
FY24:
−89.1
FY25:
−101
Change from FY21 to FY25
millions USD
FY21:
−69.5
FY22:
52.6
FY23:
−57.1
FY24:
−39.9
FY25:
−18.4
Change from FY21 to FY25
millions USD
FY21:
121
FY22:
0.09
FY23:
82.8
FY24:
118
FY25:
138
millions USD
FY21:
11.1
FY22:
18.1
FY23:
−25.5
FY24:
−11.5
FY25:
18.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−40.1
FY22:
−34.6
FY23:
−51.4
FY24:
−89.1
FY25:
−101

All amounts in millions USD Data source:SEC EDGAR